New breast cancer treatment cuts recurrence by 25%, UK study shows

Study patient Sarah Ryder, 57 said the trial had helped her ‘believe in a future again’. Picture: The Royal Marsden/PA

A new treatment for patients with a common type of breast cancer has cut the risk of recurrence by a quarter, a new study has shown.

Patients with hormone receptor positive (HR+) early stage breast cancer at a high risk of recurrence were recruited to the global randomised study led by the Royal Marsden NHS Foundation Trust.